Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which reportedly blocked proliferation of latently EBV-infected B cells in the absence of EBNA3C’s repressive epigenetic functions [23–25].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [25]
In the citing paper
“EBNA3C plays a central function to restrain transcription of p16INK4a in these cells as suggested previously [23–25].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361 · cited 2×
“thought to repress or silence genes while keeping them poised for activation [47,53].”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Since in this type of assay, the oncogene Ha-RAS alone triggers exit from the cell cycle and premature senescence via the induction of the p16 and/or p19 proteins encoded by the CDKN2A locus [23,25], this suggests that EBNA3A and EBNA3C can each rescue primary fibroblasts from growth arrest and senescence.”
BackgroundHistone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 1×
“CpG islands methylated de novo in cancer have often been previously marked by the presence of PcG proteins and H3K27me3 [58,59,60,61,62,63].”
BackgroundThe Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · cited 1×
“CpG islands methylated de novo in cancer have often been previously marked by the presence of PcG proteins and H3K27me3 [58,59,60,61,62,63].”
BackgroundEpigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143 · cited 1×
“CpG islands methylated de novo in cancer have often been previously marked by the presence of PcG proteins and H3K27me3 [58,59,60,61,62,63].”
BackgroundOhm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130 · cited 1×
“CpG islands methylated de novo in cancer have often been previously marked by the presence of PcG proteins and H3K27me3 [58,59,60,61,62,63].”
BackgroundThe Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 9×
“levels through a negative feedback loop and that Rb-negative tumours (such as carcinoma of cervix) and tumour-derived cell lines can express high levels of p16 [23,48].”
BackgroundInfluentialAgger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez-Niedenführ, M., Maertens, G., Banck, M., Zhou, M.-M., Walsh, M. J., et al. (2009) · Genes & Development · doi:10.1101/gad.511109 · Cited by 352 · cited 3×
“The H3K27me3 demethylase JMJD3 contributes to plasticity of the p16 locus, and functions in a switch from the repressive chromatin in response to oncogenic stress [45,46]”
BackgroundInfluentialYang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71 · cited 1×
“Furthermore, although it has been shown that LMP1 is a negative regulator of p16 in fibroblasts and epithelial cells [56,57], LMP1 expression was not reduced in any of the mutant LCLs studied here or reported elsewhere (Figures S1 and S3; [8,35].”
Background
Research works printed but not linked: 57
- GW Bornkamm, 2001, Molecular virology of Epstein-Barr virus., Philos Trans R Soc Lond B Biol Sci, 356, 437, 10.1098/rstb.2000.0781 · DOI
- DA Thorley-Lawson, 2004, Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas., The New England journal of medicine, 350, 1328, 10.1056/NEJMra032015 · DOI · Paper page
- JE Roughan, 2009, The intersection of Epstein-Barr virus with the germinal center., J Virol, 83, 3968, 10.1128/JVI.02609-08 · doi:10.1128/jvi.02609-08
- DH Crawford, 2001, Biology and disease associations of Epstein-Barr virus., Philos Trans R Soc Lond B Biol Sci, 356, 461, 10.1098/rstb.2000.0783 · DOI · Paper page
- R Touitou, 2005, Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells., J Gen Virol, 86, 1269, 10.1099/vir.0.80763-0 · DOI
- B Tomkinson, 1993, Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation., J Virol, 67, 2014, 10.1128/JVI.67.4.2014-2025.1993 · DOI · Paper page
- B Tomkinson, 1992, Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro., J Virol, 66, 2893, 10.1128/JVI.66.5.2893-2903.1992 · doi:10.1128/jvi.66.5.2893-2903.1992
- ML Hertle, 2009, Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes., PLoS Pathogens, 5, e1000506, 10.1371/journal.ppat.1000506 · DOI
- A Le Roux, 1994, The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter., Virology, 205, 596, 10.1006/viro.1994.1687 · doi:10.1006/viro.1994.1687
- L Waltzer, 1996, Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA., J Virol, 70, 5909, 10.1128/JVI.70.9.5909-5915.1996 · doi:10.1128/jvi.70.9.5909-5915.1996
- SA Radkov, 1999, Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription., J Virol, 73, 5688, 10.1128/JVI.73.7.5688-5697.1999 · DOI
- I Cludts, 1998, Multiple functions within the Epstein-Barr virus EBNA-3A protein., J Virol, 72, 1862, 10.1128/JVI.72.3.1862-1869.1998 · doi:10.1128/jvi.72.3.1862-1869.1998
- M Bain, 1996, Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA., J Virol, 70, 2481, 10.1128/JVI.70.4.2481-2489.1996 · DOI
- PY Bourillot, 1998, Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa., J Gen Virol, 79 (Pt2), 363, 10.1099/0022-1317-79-2-363 · doi:10.1099/0022-1317-79-2-363
- JS Knight, 2003, Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines., J Virol, 77, 4261, 10.1128/JVI.77.7.4261-4272.2003 · DOI
- R Touitou, 2001, Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C., J Virol, 75, 7749, 10.1128/JVI.75.16.7749-7755.2001 · DOI
- M Hickabottom, 2002, Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP)., J Biol Chem, 277, 47197, 10.1074/jbc.M208116200 · DOI
- G Chinnadurai, 2007, Transcriptional regulation by C-terminal binding proteins., Int J Biochem Cell Biol, 39, 1593, 10.1016/j.biocel.2007.01.025 · DOI · Paper page
- Y Shi, 2003, Coordinated histone modifications mediated by a CtBP co-repressor complex., Nature, 422, 735, 10.1038/nature01550 · DOI · Paper page
- A Dahiya, 2001, Linking the Rb and polycomb pathways., Mol Cell, 8, 557, 10.1016/S1097-2765(01)00346-X · DOI · Paper page
- EA Mroz, 2008, COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells., Cancer Res, 68, 6049, 10.1158/0008-5472.CAN-08-1279 · DOI
- GA Parker, 1996, Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7., Oncogene, 13, 2541
- GA Parker, 2000, Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis., Oncogene, 19, 700, 10.1038/sj.onc.1203327 · DOI
- T Choudhuri, 2007, The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block., J Virol, 81, 6718, 10.1128/JVI.00053-07 · DOI
- B Gruhne, 2009, Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints., Oncogene, 28, 3997, 10.1038/onc.2009.258 · DOI · Paper page
- JS Knight, 2004, Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity., J Virol, 78, 1981, 10.1128/JVI.78.4.1981-1991.2004 · DOI
- JS Knight, 2005, Epstein–Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase., Proc Natl Acad Sci U S A, 102, 18562, 10.1073/pnas.0503886102 · DOI · Paper page
- JS Knight, 2005, SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen., Mol Cell Biol, 25, 1749, 10.1128/MCB.25.5.1749-1763.2005 · DOI
- BG Bajaj, 2008, Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein., J Virol, 82, 4082, 10.1128/JVI.02500-07 · DOI
- A Saha, 2009, Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2., J Virol, 83, 4652, 10.1128/JVI.02408-08 · DOI
- F Yi, 2009, Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities., Virology, 388, 236, 10.1016/j.virol.2009.03.027 · DOI
- S Maruo, 2006, Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells., Proc Natl Acad Sci U S A, 103, 19500, 10.1073/pnas.0604919104 · DOI · Paper page
- S Maruo, 2003, Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth., J Virol, 77, 10437, 10.1128/JVI.77.19.10437-10447.2003 · doi:10.1128/jvi.77.19.10437-10447.2003
- E Anderton, 2008, Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma., Oncogene, 27, 421, 10.1038/sj.onc.1210668 · DOI · Paper page
- K Paschos, 2009, Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim., PLoS Pathogens, 5, e1000492, 10.1371/journal.ppat.1000492 · DOI · Paper page
- JA Simon, 2009, Mechanisms of Polycomb gene silencing: knowns and unknowns., Nat Rev Mol Cell Biol, 10, 697, 10.1038/nrm2763 · DOI · Paper page
- AP Bracken, 2009, Polycomb group proteins: navigators of lineage pathways led astray in cancer., Nat Rev Cancer, 9, 773, 10.1038/nrc2736 · DOI · Paper page
- HJ Delecluse, 1998, Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells., Proc Natl Acad Sci U S A, 95, 8245, 10.1073/pnas.95.14.8245 · DOI · Paper page
- RE White, 2003, Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence., J Gen Virol, 84, 3393, 10.1099/vir.0.19387-0 · doi:10.1099/vir.0.19387-0
- B Neuhierl, 2002, Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection., Proc Natl Acad Sci U S A, 99, 15036, 10.1073/pnas.232381299 · DOI
- SK Kia, 2008, SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus., Mol Cell Biol, 28, 3457, 10.1128/MCB.02019-07 · DOI · Paper page
- RG Sewalt, 1999, C-Terminal Binding Protein Is a Transcriptional Repressor That Interacts with a Specific Class of Vertebrate Polycomb Proteins., Mol Cell Biol, 19, 777, 10.1128/MCB.19.1.777 · DOI · Paper page
- L Atchison, 2003, Transcription factor YY1 functions as a PcG protein in vivo., EMBO Journal, 22, 1347, 10.1093/emboj/cdg124 · DOI · Paper page
- L Srinivasan, 2004, YY1 DNA binding and PcG recruitment requires CtBP., Genes Dev, 18, 2596, 10.1101/gad.1228204 · DOI
- AV Krivtsov, 2007, MLL translocations, histone modifications and leukaemia stem-cell development., Nature Rev Cancer, 7, 823, 10.1038/nrc2253 · DOI · Paper page
- VK Tiwari, 2008, PcG proteins, DNA methylation, and gene repression by chromatin looping., PLoS Biology, 6, 2911, 10.1371/journal.pbio.0060306 · DOI · Paper page
- S Mujtaba, 2008, Epigenetic transcriptional repression of cellular genes by a viral SET protein., Nat Cell Biol, 10, 1114, 10.1038/ncb1772 · DOI
- N Ohtani, 2003, Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5., J Cell Biol, 162, 173, 10.1083/jcb.200302085 · DOI · Paper page
- I Keshet, 2006, Evidence for an instructive mechanism of de novo methylation in cancer cells., Nat Genet, 38, 149, 10.1038/ng1719 · DOI · Paper page
- U Klangby, 1998, p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma., Blood, 91, 1680, 10.1182/blood.V91.5.1680 · DOI
- MS Lindstrom, 2002, Role of genetic and epigenetic changes in Burkitt lymphoma., Semin Cancer Biol, 12, 381, 10.1016/S1044-579X(02)00058-5 · DOI
- I Hernandez-Munoz, 2005, Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1., Mol Cell Biol, 25, 11047, 10.1128/MCB.25.24.11047-11058.2005 · DOI · Paper page
- U Schaeper, 1995, Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation., Proc Natl Acad Sci U S A, 92, 10467, 10.1073/pnas.92.23.10467 · DOI · Paper page
- AC Brown, 2006, Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus., Proc Natl Acad Sci U S A, 103, 1687, 10.1073/pnas.0507595103 · doi:10.1073/pnas.0507595103
- S Lee, 2009, Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1., J Virol, 83, 12368, 10.1128/JVI.01403-09 · DOI
- S Maruo, 2009, Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth., Proc Natl Acad Sci U S A, 106, 4419, 10.1073/pnas.0813134106 · doi:10.1073/pnas.0813134106
- PM Howley, 2009, Small DNA tumor viruses: large contributors to biomedical sciences., Virology, 384, 256, 10.1016/j.virol.2008.12.006 · DOI · Paper page
Cited by
Epstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Liang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K. M., Kieff, E., & Zhao, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616697113 · Cited by 88
Akidil, E., Albanese, M., Buschle, A., Ruhle, A., Pich, D., Keppler, O. T., & Hammerschmidt, W. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009117 · Cited by 31
McLaughlin-Drubin, M., & Munger, K. (2013) · Viruses · doi:10.3390/v5051231 · Cited by 28
Metadata
- Authors
- Skalska, L., White, R. E., Franz, M., Ruhmann, M., & Allday, M. J.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-06-10
- Volume
- 6
- Issue
- 6
- Pages
- e1000951
- ISSN
- 1553-7374
- Cited by
- 136
- References
- 14
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.